Myla Lai-Goldman

Myla P.
Lai-Goldman was the founder of CancerGuide Diagnostics, Inc., founded in 2009, where the title held was Chief Executive & Scientific Officer from 2009 to 2010.
Dr. Lai-Goldman is the founder of GeneCentric Therapeutics, Inc., founded in 2011, holding the title of Chairman since 2021.
Dr. Lai-Goldman is the founder of Personalized Science LLC, founded in 2009, serving as Managing Partner since 2009.
Current jobs include Independent Director at West Pharmaceutical Services, Inc. since 2015, Director at Council for Entrepreneurial Development, Director at NovoPath LLC since 2022, Independent Director at Quanterix Corp.
starting 2025, Director at Qvella Corp., Director at Mercy BioAnalytics, Inc. since 2023, and Venture Partner at Hatteras Venture Partners since 2011.
Former jobs include Independent Director at Sequenom, Inc. from 2013 to 2016, Medical Director at Center for Molecular Biology & Pathology from 1991 to 2004, Independent Director at Akoya Biosciences, Inc. from 2021 to 2025, Executive VP, Chief Medical & Scientific Officer at Laboratory Corporation of America Holdings from 1991 to 2008, Executive VP, Chief Medical & Scientific Officer at Roche Biomedical Laboratories, Inc., Principal at National Genetics Institute, Inc., and Principal at Viro-Med Laboratories, Inc.Education includes a doctorate from The Trustees of Columbia University in The City of New York conferred in 1983 and an undergraduate degree from the University of Pennsylvania conferred in 1979.